Daniel Sanghera - Epsilon Healthcare Interim Officer
| EPN Stock | 0.02 0.00 0.00% |
Executive
Daniel Sanghera is Interim Officer of Epsilon Healthcare
| Address | 9 Castlereagh Street, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 8296 0000 |
| Web | https://epsilonhealthcare.com.au |
Epsilon Healthcare Management Efficiency
The company has return on total asset (ROA) of (0.1925) % which means that it has lost $0.1925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.601) %, meaning that it generated substantial loss on money invested by shareholders. Epsilon Healthcare's management efficiency ratios could be used to measure how well Epsilon Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Epsilon Healthcare's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 28.6 M in 2024, whereas Change To Liabilities is likely to drop 0.00 in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michael Gold | Macquarie Technology Group | N/A | |
| B LLB | Perseus Mining | 65 | |
| Luke Clifton | Macquarie Technology Group | N/A | |
| BEc FACID | Dexus Convenience Retail | N/A | |
| BAcc BCom | Perseus Mining | 50 | |
| Michael Beck | Perseus Mining | N/A | |
| Ajesh Raithatha | Dug Technology | N/A | |
| Mark Lommers | Dug Technology | N/A | |
| Susan Scheepers | Aurelia Metals | N/A | |
| Josephine Leong | Dug Technology | N/A | |
| Sam Cruickshank | Dug Technology | N/A | |
| Rochelle Carey | Aurelia Metals | N/A | |
| LLB BA | Dexus Convenience Retail | N/A | |
| Jacqueline Barry | Dug Technology | N/A | |
| David Schummer | Perseus Mining | 52 | |
| Jason Weate | Dexus Convenience Retail | N/A | |
| Warwick Nordin | Richmond Vanadium Technology | N/A | |
| Melanie Pollard | Perseus Mining | N/A | |
| Angus Wyllie | Aurelia Metals | N/A | |
| MAICD BCom | Dexus Convenience Retail | N/A | |
| James Mystakidis | Macquarie Technology Group | N/A | |
Management Performance
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.19 |
Epsilon Healthcare Leadership Team
Elected by the shareholders, the Epsilon Healthcare's board of directors comprises two types of representatives: Epsilon Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Epsilon. The board's role is to monitor Epsilon Healthcare's management team and ensure that shareholders' interests are well served. Epsilon Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Epsilon Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiao Cui, Executive Chairman | ||
| Laura Harvey, Chief Canada | ||
| Marcelo Mora, Company Secretary | ||
| Mark Audet, CFO Sec | ||
| Sonny Didugu, Group Sec | ||
| Li Lin, Group Controller | ||
| Daniel Sanghera, Interim Officer | ||
| Diandra Phipps, Chief Health | ||
| Jim Barlow, Chief Americas |
Epsilon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Epsilon Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.82) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 9.69 M | ||||
| Shares Outstanding | 300.35 M | ||||
| Shares Owned By Insiders | 40.00 % | ||||
| Shares Owned By Institutions | 0.03 % | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 1.00 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Epsilon Stock Analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.